Elon Musk’s reported drug use has Tesla board members facing a familiar quandary: having to decide what, if anything, to do about the chief executive subjecting directors and shareholders alike to great financial and legal risk. Bloomberg’s Max Chafkin joins Ed Ludlow and Caroline Hyde on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:
Get the latest in tech from Silicon Valley and around the world here:
Connect with us on…
Twitter:
Facebook:
Instagram:
source
